TW200716615A - Stable micronized candesartan cilexetil and methods for preparing thereof - Google Patents

Stable micronized candesartan cilexetil and methods for preparing thereof

Info

Publication number
TW200716615A
TW200716615A TW095116575A TW95116575A TW200716615A TW 200716615 A TW200716615 A TW 200716615A TW 095116575 A TW095116575 A TW 095116575A TW 95116575 A TW95116575 A TW 95116575A TW 200716615 A TW200716615 A TW 200716615A
Authority
TW
Taiwan
Prior art keywords
candesartan cilexetil
methods
preparing
stable
stable micronized
Prior art date
Application number
TW095116575A
Other languages
English (en)
Inventor
Ziv Kurgan
Michael Pesachovich
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37101528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200716615(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of TW200716615A publication Critical patent/TW200716615A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW095116575A 2005-05-10 2006-05-10 Stable micronized candesartan cilexetil and methods for preparing thereof TW200716615A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US67995205P 2005-05-10 2005-05-10
US68011505P 2005-05-11 2005-05-11
US68445505P 2005-05-24 2005-05-24
US70741705P 2005-08-10 2005-08-10
US70995405P 2005-08-19 2005-08-19
US71699505P 2005-09-13 2005-09-13
US72238805P 2005-09-29 2005-09-29

Publications (1)

Publication Number Publication Date
TW200716615A true TW200716615A (en) 2007-05-01

Family

ID=37101528

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095116575A TW200716615A (en) 2005-05-10 2006-05-10 Stable micronized candesartan cilexetil and methods for preparing thereof

Country Status (10)

Country Link
US (1) US20070082055A1 (zh)
EP (2) EP1763525A2 (zh)
JP (2) JP2008505935A (zh)
KR (1) KR100978592B1 (zh)
CA (1) CA2599415C (zh)
DE (1) DE202006020979U1 (zh)
ES (1) ES2429941T3 (zh)
IL (1) IL185106A0 (zh)
TW (1) TW200716615A (zh)
WO (1) WO2006122254A2 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1763525A2 (en) * 2005-05-10 2007-03-21 Teva Pharmaceutical Industries Ltd. Stable micronized candesartan cilexetil and methods for preparing thereof
JP5595820B2 (ja) * 2010-01-15 2014-09-24 株式会社トクヤマ カンデサルタンシレキセチルの製造方法
WO2011109579A1 (en) 2010-03-04 2011-09-09 Theravance, Inc. Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof
WO2013041944A1 (en) 2011-09-19 2013-03-28 Ranbaxy Laboratories Limited Process for the preparation of micronized candesartan cilexetil
JP5930686B2 (ja) * 2011-12-07 2016-06-08 株式会社トクヤマ 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
JP6007096B2 (ja) * 2011-12-28 2016-10-12 エルメッド エーザイ株式会社 安定化カンデサルタンシレキセチル含有物の製造方法
KR20150007297A (ko) 2012-05-07 2015-01-20 바이엘 파마 악티엔게젤샤프트 니페디핀 및 칸데사르탄 실렉세틸을 포함하는 제약 투여 형태의 제조 방법
EP2952187A4 (en) 2013-01-30 2016-08-17 Sawai Seiyaku Kk PHARMACEUTICAL COMPOSITION WITH CANDESARTAN CILEXETIL
JP2016106139A (ja) * 2016-03-07 2016-06-16 株式会社トクヤマ 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5703110A (en) * 1990-04-27 1997-12-30 Takeda Chemical Industries, Ltd. Benzimidazole derivatives, their production and use
US6004989A (en) * 1990-04-27 1999-12-21 Takeda Chemical Industries, Ltd. Benzimidazole derivatives, their production and use
DE4023369A1 (de) * 1990-07-23 1992-01-30 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
TW284688B (zh) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
JP2730501B2 (ja) 1994-01-28 1998-03-25 武田薬品工業株式会社 テトラゾリル化合物の製造法
ES2147798T3 (es) * 1994-01-28 2000-10-01 Takeda Chemical Industries Ltd Un procedimiento para la produccion de compuestos de tetrazolilo.
JP3003030B2 (ja) * 1997-05-26 2000-01-24 武田薬品工業株式会社 アミノベンゼン化合物の製造法
SE9901667D0 (sv) * 1999-05-07 1999-05-07 Astra Ab Method and device for forming particles
CN1204125C (zh) * 2000-12-27 2005-06-01 中国科学院上海药物研究所 坎地沙坦酯的合成新路线
WO2003014112A1 (fr) * 2001-08-03 2003-02-20 Takeda Chemical Industries, Ltd. Cristal et procede de fabrication correspondant
EP1742938A1 (en) * 2004-05-05 2007-01-17 Teva Pharmaceutical Industries Ltd. Preparation of candesartan cilexetil in high purity
WO2005123720A1 (en) * 2004-06-18 2005-12-29 Ranbaxy Laboratories Limited Fine particles of the angiotensin ii antagonist candesartan cilexetil and process for production thereof
CA2594332A1 (en) * 2005-01-06 2006-07-13 Elan Pharma International Ltd. Nanoparticulate candesartan formulations
EP1763525A2 (en) * 2005-05-10 2007-03-21 Teva Pharmaceutical Industries Ltd. Stable micronized candesartan cilexetil and methods for preparing thereof

Also Published As

Publication number Publication date
US20070082055A1 (en) 2007-04-12
EP2210888A3 (en) 2010-09-15
KR100978592B1 (ko) 2010-08-27
EP1763525A2 (en) 2007-03-21
CA2599415C (en) 2011-07-19
CA2599415A1 (en) 2006-11-16
WO2006122254A3 (en) 2007-01-25
JP2010270148A (ja) 2010-12-02
WO2006122254A2 (en) 2006-11-16
KR20070062500A (ko) 2007-06-15
EP2210888A2 (en) 2010-07-28
EP2210888B1 (en) 2013-04-24
JP2008505935A (ja) 2008-02-28
IL185106A0 (en) 2007-12-03
ES2429941T3 (es) 2013-11-18
DE202006020979U1 (de) 2011-08-05

Similar Documents

Publication Publication Date Title
TW200716615A (en) Stable micronized candesartan cilexetil and methods for preparing thereof
JO2793B1 (en) The new crystalline form 5 of agomelatine, its preparation process and the pharmaceutical ingredients it contains
MX346318B (es) Cristales.
MX2009004746A (es) Derivados de 1,2,4-triazol como inhibidores del receptor sigma.
MY151003A (en) Stable pharmaceutical composition comprising a pyrimidine-sulfamide
TW200726753A (en) 2,4-diamino-pyrimidines as aurora inhibitors
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
UA94833C2 (en) Substituted bicyclolactams
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
UA86595C2 (ru) Гамма-кристаллическая форма гидрохлорида ивабрадина, способ ее получения и фармацевтическая композиция, которая ее содержит
UA98138C2 (ru) Производные бензамида как модуляторы фолликулостимулирующего гормона
UA97351C2 (ru) Производная кумарина, имеющая противоопухолевую активность
MX2007003175A (es) Medicamentos que contienen compuestos de carbonilo y su uso.
TW200621262A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
WO2009010871A3 (en) Pyrazole derivatives as antagonists of adenosine a3 receptor
MX2007012936A (es) Derivados de dihidrobenzofurano y usos de los mismos.
TN2012000246A1 (en) Pharmaceutical compositions comprising sigma receptor ligands
JO2937B1 (en) Tight muscles of the peptide vascular tensioner receptor
MY151295A (en) Pyrimidyl indoline compound
UA103179C2 (ru) Фармацевтическая композиция, которая содержит эзетимиб
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases
MX2010001020A (es) Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas.
WO2006077024A3 (en) 5-aminoindole derivatives
TW200716547A (en) Piperidin-4-yl-amide derivatives
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process